To address these questions, we investigated the ability of three validated tissue-specific IR indices to predict the deterioration of hyperglycemia, incident type 2 diabetes and CVD events in participants of the Metabolic Syndrome in Men (METSIM) Study, and compared their predictive power with that of fasting plasma insulin level. Here, INS is linked to type 2 diabetes mellitus.